Feng Chi Biotech Corp. (6744.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$14.45 (+0.00%) as of
Key statistics
- Market cap
- 222.53M
- P/E (TTM)
- 22.23
- EPS (TTM)
- 0.65
- Dividend yield
- 5.81%
- 52-week range
- 13.30 – 20.00
- Beta
- 0.30
- Revenue (TTM)
- 156.99M
- Profit margin
- 6.31%
- Volume
- 1.00k
About Feng Chi Biotech Corp.
Feng Chi Biotech Corp. engages in the wholesale and retail of medical devices and precision instruments and biotechnology services in Taiwan and internationally. The company provides preimplantation genetic testing, prenatal testing, precision medicine, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services, as well as infectious disease detection services. It also distributes various genetic and medical testing services. The company was founded in 1992 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.